HEADER NUCLEAR PROTEIN 07-FEB-23 8CH8 TITLE CRYSTAL STRUCTURE OF THE HUMAN PXR LIGAND-BINDING DOMAIN IN COMPLEX TITLE 2 WITH LIRANAFTATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ORPHAN NUCLEAR RECEPTOR PAR1,ORPHAN NUCLEAR RECEPTOR PXR, COMPND 5 PREGNANE X RECEPTOR,STEROID AND XENOBIOTIC RECEPTOR,SXR; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1I2, PXR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS NUCLEAR RECEPTOR, PREGNANE X RECEPTOR, NUCLEAR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.CARIVENC,Q.DEROSA,M.GRIMALDI,A.BOULAHTOUF,P.BALAGUER,W.BOURGUET REVDAT 1 21-FEB-24 8CH8 0 JRNL AUTH C.CARIVENC,Q.DEROSA,M.GRIMALDI,A.BOULAHTOUF,P.BALAGUER, JRNL AUTH 2 W.BOURGUET JRNL TITL CRYSTAL STRUCTURE OF THE HUMAN PXR LIGAND-BINDING DOMAIN IN JRNL TITL 2 COMPLEX WITH LIRANAFTATE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 64.81 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.440 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.4 REMARK 3 NUMBER OF REFLECTIONS : 19560 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.970 REMARK 3 FREE R VALUE TEST SET COUNT : 1750 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 64.8100 - 4.9300 1.00 3025 116 0.1776 0.2007 REMARK 3 2 4.9300 - 3.9200 1.00 2968 150 0.1702 0.1751 REMARK 3 3 3.9100 - 3.4200 1.00 3005 159 0.2013 0.2175 REMARK 3 4 3.4200 - 3.1100 1.00 3019 119 0.2379 0.2717 REMARK 3 5 3.1100 - 2.8800 1.00 2958 168 0.2386 0.2859 REMARK 3 6 2.8800 - 2.7100 1.00 3024 148 0.2424 0.2890 REMARK 3 7 2.7100 - 2.5800 1.00 2988 168 0.2348 0.2398 REMARK 3 8 2.5800 - 2.4700 0.99 2894 181 0.2441 0.2590 REMARK 3 9 2.4700 - 2.3700 0.95 2849 144 0.2637 0.2547 REMARK 3 10 2.3700 - 2.2900 0.87 2568 141 0.2816 0.2647 REMARK 3 11 2.2900 - 2.2200 0.76 2262 145 0.2950 0.3086 REMARK 3 12 2.2200 - 2.1500 0.65 1926 111 0.3230 0.3548 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.234 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.983 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.54 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 62.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2262 REMARK 3 ANGLE : 0.708 3070 REMARK 3 CHIRALITY : 0.040 338 REMARK 3 PLANARITY : 0.004 404 REMARK 3 DIHEDRAL : 17.718 328 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8CH8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1292128514. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-OCT-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.619923 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20353 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 64.810 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.1 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.75100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50-100 MM IMIDAZOLE, 8-14% REMARK 280 ISOPROPANOL, VAPOR DIFFUSION, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.87200 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 45.82450 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 45.82450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 64.30800 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 45.82450 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 45.82450 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 21.43600 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 45.82450 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.82450 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 64.30800 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 45.82450 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.82450 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 21.43600 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 42.87200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 119 REMARK 465 LYS A 120 REMARK 465 LYS A 121 REMARK 465 GLY A 122 REMARK 465 HIS A 123 REMARK 465 HIS A 124 REMARK 465 HIS A 125 REMARK 465 HIS A 126 REMARK 465 HIS A 127 REMARK 465 HIS A 128 REMARK 465 GLY A 129 REMARK 465 SER A 130 REMARK 465 GLU A 131 REMARK 465 ARG A 132 REMARK 465 THR A 133 REMARK 465 GLY A 134 REMARK 465 THR A 135 REMARK 465 GLN A 136 REMARK 465 PRO A 137 REMARK 465 LEU A 138 REMARK 465 GLY A 139 REMARK 465 SER A 179 REMARK 465 SER A 180 REMARK 465 GLY A 181 REMARK 465 CYS A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 SER A 187 REMARK 465 LEU A 188 REMARK 465 GLN A 189 REMARK 465 ALA A 190 REMARK 465 PRO A 191 REMARK 465 SER A 192 REMARK 465 ARG A 193 REMARK 465 GLU A 194 REMARK 465 GLU A 195 REMARK 465 THR A 311 REMARK 465 ALA A 312 REMARK 465 GLY A 313 REMARK 465 LEU A 435 REMARK 465 VAL A 436 REMARK 465 PRO A 437 REMARK 465 ARG A 438 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 140 CG1 CG2 REMARK 470 GLN A 141 CG CD OE1 NE2 REMARK 470 GLU A 146 CG CD OE1 OE2 REMARK 470 LEU A 178 CG CD1 CD2 REMARK 470 ARG A 203 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 204 CG CD CE NZ REMARK 470 LEU A 209 CG CD1 CD2 REMARK 470 LYS A 210 CG CD CE NZ REMARK 470 GLU A 218 CG CD OE1 OE2 REMARK 470 LYS A 226 CG CD CE NZ REMARK 470 LYS A 234 CG CD CE NZ REMARK 470 ARG A 303 NE CZ NH1 NH2 REMARK 470 ASP A 310 CG OD1 OD2 REMARK 470 PHE A 315 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 316 CG CD OE1 NE2 REMARK 470 LEU A 318 CG CD1 CD2 REMARK 470 LEU A 319 CG CD1 CD2 REMARK 470 LEU A 320 CG CD1 CD2 REMARK 470 LYS A 325 CD CE NZ REMARK 470 LYS A 332 CD CE NZ REMARK 470 HIS A 359 ND1 CD2 CE1 NE2 REMARK 470 ARG A 360 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 364 CG CD OE1 NE2 REMARK 470 GLN A 409 CD OE1 NE2 REMARK 470 ARG A 410 CZ NH1 NH2 REMARK 470 LEU A 411 CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 163 O HOH A 601 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 152 CA - CB - CG ANGL. DEV. = 13.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 301 65.61 -102.49 REMARK 500 PHE A 349 44.94 -90.86 REMARK 500 PHE A 420 -18.56 -159.47 REMARK 500 REMARK 500 REMARK: NULL DBREF 8CH8 A 130 434 UNP O75469 NR1I2_HUMAN 130 434 SEQADV 8CH8 MET A 119 UNP O75469 INITIATING METHIONINE SEQADV 8CH8 LYS A 120 UNP O75469 EXPRESSION TAG SEQADV 8CH8 LYS A 121 UNP O75469 EXPRESSION TAG SEQADV 8CH8 GLY A 122 UNP O75469 EXPRESSION TAG SEQADV 8CH8 HIS A 123 UNP O75469 EXPRESSION TAG SEQADV 8CH8 HIS A 124 UNP O75469 EXPRESSION TAG SEQADV 8CH8 HIS A 125 UNP O75469 EXPRESSION TAG SEQADV 8CH8 HIS A 126 UNP O75469 EXPRESSION TAG SEQADV 8CH8 HIS A 127 UNP O75469 EXPRESSION TAG SEQADV 8CH8 HIS A 128 UNP O75469 EXPRESSION TAG SEQADV 8CH8 GLY A 129 UNP O75469 EXPRESSION TAG SEQADV 8CH8 LEU A 435 UNP O75469 EXPRESSION TAG SEQADV 8CH8 VAL A 436 UNP O75469 EXPRESSION TAG SEQADV 8CH8 PRO A 437 UNP O75469 EXPRESSION TAG SEQADV 8CH8 ARG A 438 UNP O75469 EXPRESSION TAG SEQRES 1 A 320 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLU SEQRES 2 A 320 ARG THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR SEQRES 3 A 320 GLU GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA SEQRES 4 A 320 GLN MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS SEQRES 5 A 320 ASN PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU SEQRES 6 A 320 LEU PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA SEQRES 7 A 320 ALA LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU SEQRES 8 A 320 LYS VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL SEQRES 9 A 320 TRP ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU SEQRES 10 A 320 ILE PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR SEQRES 11 A 320 TYR MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SEQRES 12 A 320 SER TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER SEQRES 13 A 320 LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG SEQRES 14 A 320 PHE ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU SEQRES 15 A 320 CYS GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY SEQRES 16 A 320 GLY PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE SEQRES 17 A 320 HIS TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU SEQRES 18 A 320 TYR VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP SEQRES 19 A 320 ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU SEQRES 20 A 320 GLN GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU SEQRES 21 A 320 CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU SEQRES 22 A 320 LYS ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN SEQRES 23 A 320 ALA GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE SEQRES 24 A 320 HIS PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY SEQRES 25 A 320 ILE THR GLY SER LEU VAL PRO ARG HET ULC A 501 23 HETNAM ULC ~{O}-(5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL) ~{N}-(6- HETNAM 2 ULC METHOXYPYRIDIN-2-YL)-~{N}-METHYL-CARBAMOTHIOATE FORMUL 2 ULC C18 H20 N2 O2 S FORMUL 3 HOH *68(H2 O) HELIX 1 AA1 THR A 144 PHE A 162 1 19 HELIX 2 AA2 ALA A 197 CYS A 207 1 11 HELIX 3 AA3 GLY A 233 SER A 238 5 6 HELIX 4 AA4 LEU A 239 ILE A 261 1 23 HELIX 5 AA5 ILE A 261 ASP A 266 1 6 HELIX 6 AA6 PRO A 268 VAL A 291 1 24 HELIX 7 AA7 PHE A 315 LEU A 319 1 5 HELIX 8 AA8 GLU A 321 LEU A 333 1 13 HELIX 9 AA9 HIS A 336 PHE A 349 1 14 HELIX 10 AB1 GLN A 358 ARG A 381 1 24 HELIX 11 AB2 GLN A 383 ARG A 387 5 5 HELIX 12 AB3 PHE A 388 HIS A 418 1 31 HELIX 13 AB4 THR A 422 PHE A 429 1 8 SHEET 1 AA1 5 VAL A 222 TYR A 225 0 SHEET 2 AA1 5 VAL A 211 ARG A 216 -1 N LEU A 213 O TYR A 225 SHEET 3 AA1 5 LEU A 304 LEU A 308 -1 O CYS A 307 N SER A 212 SHEET 4 AA1 5 THR A 298 CYS A 301 -1 N CYS A 301 O LEU A 304 SHEET 5 AA1 5 PHE A 292 ASN A 293 -1 N ASN A 293 O THR A 298 CRYST1 91.649 91.649 85.744 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010911 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010911 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011663 0.00000